Sugi Predict

Sugi Predict / Compounds / SCHEMBL24253952

SCHEMBL24253952

SCHEMBL24253952

O=C1CCCC2(CCN(c3cc(C(F)(F)F)nc(Cl)n3)CC2)N1c1ccc(F)c(F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.34
▸ HCRTR1 O43613 2/20 0.33
▸ HCRTR2 O43614 2/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ LTC4S Q16873 1/20 0.33
▸ DRD2 P14416 6/20 0.33
▸ DRD3 P35462 5/20 0.33
▸ HTR1A P08908 1/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ ADRA1B P35368 1/20 0.32
▸ SLC6A2 P23975 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31
▸ CTSS P25774 2/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24253946 0.89 KDM4E (0.32) MAPTHCRTR1HCRTR2KCNH2LTC4S
SCHEMBL30006991 0.89 KDM4E (0.32) MAPTHCRTR1HCRTR2KCNH2LTC4S
SCHEMBL30423952 0.86 HCRTR1 (0.34) HCRTR1HCRTR2KCNH2LTC4SDRD2
SCHEMBL30424528 0.86 FFAR4 (0.34) HCRTR1HCRTR2KCNH2LTC4SDRD2
SCHEMBL24253948 0.86 HCRTR1 (0.34) HCRTR1HCRTR2KCNH2LTC4SDRD2
SCHEMBL24253953 0.86 FFAR4 (0.34) HCRTR1HCRTR2KCNH2LTC4SDRD2
SCHEMBL30494558 0.86 KCNH2 (0.34) HCRTR1HCRTR2KCNH2LTC4SDRD2
SCHEMBL24253842 0.86 KCNH2 (0.34) HCRTR1HCRTR2KCNH2LTC4SDRD2
SCHEMBL24253742 0.85 DRD3 (0.39) DRD2DRD3
SCHEMBL30423984 0.85 DRD3 (0.39) DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11708366-B2 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof NOVARTIS AG (CH) 2023-07-25 — — US disclosed
US-11708366-B2 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof NOVARTIS AG (CH) 2023-07-25 — — US disclosed
EP-4196478-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF Novartis AG (CH) 2023-06-21 — — EP disclosed
CN-116157404-A Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof 诺华股份有限公司 2023-05-23 — — CN disclosed
US-20220048909-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708366-B2 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof REN, NR3C2, PKD1 MAPT 4450/4885HCRTR1 2245/4885HCRTR2 3027/4885
US-20220048909-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF REN, NR3C2, PKD1 MAPT 4450/4885HCRTR1 2245/4885HCRTR2 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.